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SuMMARy – Surgical site infection (SSi) is a significant factor of morbidity and mortality in 
patients surgically treated for laryngeal carcinoma. The aim of this prospective study in 277 patients 
was to determine the incidence of SSi in patients surgically treated for laryngeal squamous cell 
carcinoma and to identify risk factors for development of SSi. Patients with previous chemotherapy 
and/or radiotherapy were excluded. All patients had tracheostomy postoperatively and received an-
tibiotic prophylaxis with cephalosporin, aminoglycoside and metronidazole. The overall incidence 
of SSis in our cohort was 6.5% (18 patients): 4 (22.22%) patients with superficial infections, 11 
(61.11%) with deep infections and 3 (16.66%) with organ-space infections. The remaining infections 
included pneumonia (1 case) and Clostridium difficile colitis (2 cases). The median hospital stay in 
patients having developed SSis was longer than in those without SSis (33.5 vs. 16 days, p<0.001). By 
using univariate analysis American Society of Anesthesiologists score ≥3, duration of surgery longer 
than 120 minutes and national nosocomial infections Surveillance risk index ≥1 were found to be 
significantly associated with the occurrence of SSi. Age, sex, body mass index, history of smoking, 
underlying diabetes and preoperative length of stay were found not to be associated with SSi. The 
most frequently isolated microorganism was Klebsiella spp.
key words: Surgical wound infection; Head and neck neoplasms – surgery; Head and neck neoplasms – 
complications; Laryngeal neoplasms – epidemiology; Risk factors
Correspondence to: Jelena Sotirović, MD, ent Department, Mi-
litary Medical Academy, Crontravska 17, Belgrade, Serbia
e-mail: j.sotirovic@gmail.com
Received January 27, 2014, accepted January 26, 2015
Introduction
loco-regional control of laryngeal cancer and 
good survival outcome can be achieved through sur-
gery and organ-preserving radiotherapy or chemo/ra-
diotherapy with advantages and disadvantages of each 
modality of treatment. Surgical resection still remains 
the mainstay of curative treatment for head and neck 
malignancy1.
One of the most common complications of surgery 
is surgical site infection (SSi) despite all sterility prin-
ciples used. SSi is a significant factor of morbidity and 
mortality in patients surgically treated for laryngeal 
malignant disease2,3. 
According to the Centers for Disease Control and 
Prevention (CDC) from Atlanta, SSi can be classified 
as incisional (superficial or deep) and organ/space4,5. 
The national Research Council classifies operative 
site as clean, clean-contaminated, contaminated, and 
dirty/infected. Surgical site in oral cavity, pharynx 
and larynx represents a clean-contaminated surgi-
cal site due to the presence of normal flora6. Bacteria 
colonizing oral cavity are an important factor in noso-
comial infections7.
in laryngeal cancer surgery, SSi leads to wound 
dehiscence, formation of pharyngo-cutaneous fistula, 
and in severe cases sepsis and death. it can prolong 
hospital stay, increase health care costs, delay speech 
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rehabilitation, oral nutrition and postoperative ad-
juvant therapy, which in turn may affect the overall 
prognosis. SSi may cause poor cosmetic results and 
have significant psychological effect on the patient 
affecting his/her quality of life. Several authors also 
found that patients with head and neck cancer with 
local or regional infection were more likely to have 
recurrent disease8,9. 
Data on SSi in laryngeal and/or pharyngeal cancer 
surgery are not so numerous. Reports on the incidence 
of SSi in oncologic surgery for head and neck malig-
nancy differ, ranging from 10% to 45%9-14. Analyses 
of series of patients revealed a large number of risk 
factors for postoperative SSi in head and neck cancer 
surgery, such as various disease, patient and operative 
characteristics, preoperative radiotherapy or chemo-
therapy15. 
The aim of this study was to assess the incidence 
of SSi in patients surgically treated for laryngeal 
squamous cell carcinoma at a tertiary health care in-
stitution and to identify risk factors for development 
of SSi.
Patients and Methods 
This prospective study included a cohort of 277 
patients with squamous cell carcinoma of the larynx 
confirmed by histopathology. All 277 patients un-
derwent surgery as primary modality of treatment 
between february 2006 and December 2011 at the 
ear, nose and Throat Department, Military Medical 
Academy (MMA), Belgrade, Serbia. infection con-
trol personnel collected general data on each patient 
under surveillance: age, gender, history of smoking, 
body mass index (BMi), presence of underlying dia-
betes mellitus, American Society of Anesthesiolo-
gists (ASA) score, as well as health care related data 
including duration of surgery, preoperative length 
of stay (lOS), length of hospital stay, and national 
nosocomial infections Surveillance (nniS) System 
risk index. 
The nniS System risk index was calculated on the 
basis of data related to the operation: wound contami-
nation class, duration of surgery, and ASA score. The 
nniS System index ranges from 0 to 3. each of three 
risk indices is worth 1 point: contaminated or dirty 
surgical wound, ASA scores greater than 2, and dura-
tion of surgery greater than the 75th percentile for a 
specific group of surgical procedures16,17. 
Surgical procedures included partial and total 
laryngectomy with or without partial pharyngec-
tomy, resection of the base of the tongue, and neck 
dissection according to the stage of the disease. We 
did not have patients with free flap reconstruction or 
major blood loss during surgery. All patients had tra-
cheostomy postoperatively, temporary or permanent. 
Surgery was performed by four surgeons with more 
than 10-year experience in laryngeal surgery. Surgical 
site was shaved with razor the day before the surgery 
and disinfected with povidone-iodine preoperatively 
observing the general rules of sterility. All included 
patients received antibiotic prophylaxis with cepha-
losporin, aminoglycoside and metronidazole during 
the surgery, continuing for 4 days postoperatively. 
Surgical drain was removed on the third postoperative 
day. All patients were monitored at the intensive Care 
unit immediately after the surgery and transferred to 
the ent Department on the next day. 
until discharge from the hospital, SSis were as-
sessed on a daily basis. for diagnosis of SSi, the 
CDC criteria were used4,18. The outcome of interest 
was defined as the presence of purulent discharge 
from the incision wound or tracheostoma, spontane-
ous dehiscence of the wound with signs of infection, 
or the presence of pharyngo-cutaneous fistula. in all 
cases of SSi, microbial smear was taken and immedi-
ate empirical antimicrobial treatment was started with 
correction of therapy according to the culture result. 
Drainage of infected wound and placement of naso-
gastric feeding tube (if needed) was performed. 
Microbiological testing was performed at the 
MMA institute of Medical Microbiology. isolates 
were identified by routine methods19. Susceptibility 
testing was done according to the Clinical and labo-
ratory Standard institute recommendations20. 
Statistical analysis was performed using the SPSS 
15.0 software (Chicago, illinois, uSA). Data are pre-
sented as mean ± SD, range (minimum, maximum) 
and count (%). The univariate relationship between 
each variable and SSi was analyzed with logistic re-
gression. Only variables with p value less than 0.1 in 
univariate analysis and variables that could be a po-
tential risk factor for infection were entered in the 
multivariate logistic regression model.
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Results
Patients were stratified into two groups based on 
the presence or absence of SSi. The overall incidence 
of SSi and lOS were calculated in the two groups of 
patients. Patient characteristics and predictive factors 
related to SSi according to the univariate analysis are 
shown in table 1.
Incidence of SSI 
eighteen (6.5%) of 277 patients that underwent 
laryngeal surgery for squamous cell carcinoma had 
SSi postoperatively. Out of 18 SSis, there were four 
(22.22%) patients with superficial infections, 11 
(61.11%) with deep infections and three (16.66%) 
with organ-space infections. The remaining infections 
included pneumonia (1 case) and Clostridium difficile 
colitis (2 cases).
Study population characteristics 
The mean age of the study population was 59.48 
(range 34 to 82, median 59.00) years. There were few-
er females (n=31; 11.2%) than males (n=246; 88.8%).
Preoperative variable and SSI
When surgical procedures were grouped by ASA 
preoperative assessment score, there were 1.8% (5 pa-
tients) of surgical procedures with patient ASA score 
1 and incidence rate of infection 0%; 87.4% (n=242) 
with ASA score 2 and incidence rate of infection 
5.4%; 10.8% (n=30) with ASA score 3 and incidence 
rate of infection 16.7%; we did not have patients with 
ASA score 4 or 5. univariate analysis showed the oc-
currence of SSis to be significantly associated with 
ASA score ≥3 (p<0.05; OR 3.600). Age, sex, BMi, 
history of smoking and underlying diabetes were not 
associated with SSis.
Table 1. Relationship between patient characteristics, predictive factors and surgical site infection
factor Category Patients with SSi (%)
Patients without 
SSi (%) p value
OR 
(95% Ci)






































































OR = odds ratio; Ci = confidence interval; SSi = surgical site infection; BMi = body mass index; ASA = American Society of Anesthesiologists 
score; preoperative lOS = preoperative length of stay; DM = diabetes mellitus; nniS = national nosocomial infections Surveillance risk index
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Health care related data
The mean duration of surgical procedure was 
107.02 minutes, varying from 40 to 240 minutes 
(100.00±38.139). logistic regression analysis showed 
that duration of surgery longer than 120 minutes 
(p<0.05; OR 2.624) was a significant factor for devel-
oping SSi postoperatively. 
Within the group of surgical procedures classified 
by the nniS System risk index, there were 83.4% 
(n=231) of surgical procedures with risk index 0 and 
incidence rate of infection of 5.2%; 15.5% (n=43) with 
risk index 1 and incidence rate of 9.3%; and 1.1% (n=3) 
with risk index 2 and incidence rate of 66.7%; in our 
study, we did not have any patient with nniS Sys-
tem risk index 3. univariate analysis revealed that the 
occurrence of SSi was significantly associated with 
nniS risk index ≥1 (p=0.057; OR 2.737).
The median preoperative lOS was 4.42 days, 
range 0 to 48 days. Preoperative lOS for patients 
with SSi was 6.06 days and for patients without SSi 
4.31 days, with no statistically significant difference 
between these two groups of patients. 
The median lOS was 17 days (19.04±10.394), range 
6 to 71 days. Hospital stay was longer in patients that 
developed SSis than in those without SSis (p<0.001). 
The median lOS was 33.50 (37.22±15.528) days in 
patients that acquired SSi and 16.00 (17.78±8.662) 
days in patients without SSi. 
ASA and duration of surgery as significant factors 
in univariate analysis were analyzed by multivariate 
logistic regression analysis, which did not recognize 
either of them as a statistically significant predictor 
for SSi (table 2).
Microorganisms
Microorganisms were isolated in 16 (88.9%) of 
18 patients with recorded SSis. Among these, one 
species was isolated in 68.75% (n=11), 2 species in 
31.25% (n=5) and 3 species in 0% (n=0) of patients 
with SSis. The most frequently isolated microorgan-
isms were Klebsiella spp. (25%; 4/16), Streptococcus spp. 
(18.75%; 3/16), Pseudomonas aeruginosa (12.5%; 2/16) 
and Pseudomonas spp. (12.5%; 2/16), followed by En-
terobacter, Enterococcus spp., Morganella spp., Acineto-
bacter, Stenotrophomonas and Staphylococcus aureus with 
one case of infection each (6.25%; 1/16).
Discussion
Surgical site infection is one of the most common 
nosocomial infections in hospital patients in Serbia21. 
The severity of SSi varies from mild to life threaten-
ing. 
The overall SSi incidence in this prospective study 
of surgically treated laryngeal cancer patients was 
6.5%. The incidence of SSi in patients undergoing 
head and neck surgery for malignant disease has been 
reported to be as high as 45%22. Suljagic et al.2 report 
an overall SSi incidence in head and neck surgery of 
3%, Ogihara et al. on 10.0%10, Cunha et al. on 10.9%15 
and lee et al. on 18,4%22. Most of them included clean 
surgical procedures such as neck dissection, thyroidec-
tomy or salivary gland excision2,10,15,22. Contamination 
of surgical sight is recognized as a risk factor for SSi 
along with patient characteristics, type of surgery 
and other factors22,23. By penetrating into bacterially 
colonized mucosal surfaces, laryngeal and pharyngeal 
surgery presents a clean-contaminated surgical pro-
cedure according to the national Research Council 
operative-site classification. Operative exposure of the 
larynx and pharynx may lead to surgical site coloniza-
tion and infection. 
Reported data on SSi incidence in laryngeal and/
or pharyngeal cancer surgery vary among different 
authors from 4.8% to 58%10,15,22,24,25. A large number 
of studies included patients with previous chemo-
therapy and/or radiotherapy, blood loss and free flap 
reconstruction, recognizing them as risk factors for 
developing SSi10,13,14,25-29. A small number of SSi in 
this study was probably due to our selection of patients 
with no previous radiotherapy, chemotherapy or tra-
cheostomy. Comparing to Cunha et al.15 with 100% 
of deep incisional infections, 61.11% of our SSis were 
deep infections.   
Table 2. Multivariate logistic regression analysis 
p OR (95% Ci)
ASA 0.180  3.231 (0.582-17.954)
Duration of 
operation 0.090 2.399 (0.871-6.604)
nniS 0.985 0.985 (0.193-5.028)
OR = odds ratio; Ci = confidence interval; ASA = American Society 
of Anesthesiologists score; nniS = national nosocomial infections 
Surveillance risk index
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Besides SSi, Ogihara et al.10 and Cunha et al.15 re-
port on respiratory infections, meningitis and urinary 
infections after head and neck tumor surgical proce-
dures, whereas in our study we had two patients with 
Clostridium difficile colitis and one case of pneumonia, 
which can be life threatening30. 
We identified significant risk factors for develop-
ing SSi in patients undergoing laryngeal or laryngo-
pharyngeal cancer surgery. By using a univariate ap-
proach, we were able to identify 3 risk factors with the 
potential to discriminate between subjects with and 
without SSi. We found that ASA score ≥3, duration 
of surgery ≥120 minutes and nniS risk ≥1 were as-
sociated with a significant increase in SSi in patients 
with laryngeal carcinoma. 
ASA score divides patients into 5 categories ac-
cording to the American Society of Anesthesiologists 
classification. in our study, ASA score 3 (we did not 
have patients with ASA score 4 and 5) was a signifi-
cant risk factor for SSi, which agrees with the find-
ings reported by other authors22,31. 
extended operative time has been associated with 
an increased risk of SSi. Operative time longer than 
2 hours is recognized as an independent risk factor 
for SSi in cancer surgery31. This is due to the more 
advanced stage of disease and possible concomitant 
diseases in the patient, greater tissue damage, blood 
loss, and damage to local blood vessels compromising 
intraoperative antibiotic tissue levels over time. By us-
ing univariate analysis we also found the patients with 
the duration of surgery longer than 120 minutes to be 
at a higher risk of SSi. 
The nniS basic SSi risk index is composed of the 
following criteria: American Society of Anesthesiolo-
gists score of 3, 4, or 5; wound class; and duration of 
surgery32. The nniS risk score is calculated from the 
following data: ASA score, wound class and duration 
of surgery. it was found to be positively correlated with 
the risk of SSi32,33. in our study, univariate analysis 
revealed that nniS index ≥1 was related to a higher 
incidence of SSi. By univariate analysis, Petrosillo et 
al. also found the nniS score >0 to be significantly 
associated with SSi occurrence34. univariate analysis 
in a tertiary care hospital in greece showed that the 
nniS risk index of 2 or 3 was significantly associated 
with an increased risk of SSi35.
Although nniS score is a reliable, accurate and 
useful tool for identifying general surgical patients at 
risk of SSi, it does not incorporate factors specifically 
relevant to the cancer population. Cancer patients are 
a specific patient population with an increased risk of 
developing SSi. Malignant tumor is identified as an 
independent factor for SSi in head and neck surgery 
and in noncolorectal abdominal surgery10,36. 
The length of hospital stay prior to surgery greater 
than 48 hours is a previously recognized risk factor 
for SSi15,33,37. The reason is patient colonization with 
intrahospital microbial flora. in contrast, in our study, 
longer preoperative stay in hospital (longer than 2 
days) was not significantly associated with SSi on 
univariate analysis.
Regarding age, sex, BMi, history of smoking and 
underlying diabetes, there was no significant differ-
ence between the groups with and without SSi, simi-
lar to the results reported by Ogihara et al.10 and Hi-
rakawa et al.24.
The present study showed that the causative agents 
of SSis were similar to the causative agents reported 
by the authors from Portugal and uk15,25. 
The overall rate of SSi was smaller than reported in 
other studies. Postoperative infection can be reduced 
with antibiotic prophylaxis38. in order to prevent in-
fection in laryngeal and pharyngeal cancer surgery, we 
use a combination of antibiotic agents covering aerobic, 
anaerobic and gram-negative bacteria intraoperative-
ly, followed by their administration for 4 days more, 
considering it superior to single agents. Some authors 
report that prolonged and one-day antibiotic regimens 
for clean-contaminated procedures were similar in ef-
ficacy39-41. in some countries, one-day course of antibi-
otic is a standard protocol after head and neck surgery, 
while prolonged antibiotic courses are still frequently 
used in common surgical practice in Japan, particu-
larly in clean-contaminated procedures10. not all pro-
cedures need prophylaxis. Roumbelaki et al. observed 
the use of prophylactic antibiotics for 76% of clean 
procedures, extended duration of prophylaxis and 
excessive use of antibiotic combinations at a tertiary 
hospital in greece35. Clean-contaminated procedures 
have a higher incidence of postoperative infections41. 
Patients undergoing clean-contaminated surgical pro-
cedures in the upper aerodigestive tract may require 
antibiotic prophylaxis and close monitoring. This is 
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particularly important in patients with postoperative 
tracheostomy, as was the case in our study. Penel et 
al.9 report on a high occurrence of wound infection 
despite antibiotic prophylaxis. This study identified 
post-laryngectomy tracheostomy as a major risk factor 
for SSi and concluded that long-term curative anti-
biotherapy must be evaluated in cancer head and neck 
surgery requiring post-laryngectomy tracheostomy. 
lee et al.22 also found that SSi was significantly high-
er in patients with tracheostomy. 
in contrast to the low incidence of infection, over-
administration of antibiotics is a potential risk for an-
tibiotic resistance, increased costs, adverse reactions 
and development of Clostridium difficile colitis42,43. in 
our study, we had 2 cases of Clostridium difficile colitis, 
so shortest effective regimen should be used. 
A clear limitation of this study was a small sample 
size of patients with SSi in the cohort, which reduced 
the statistical power achievable. Also, the sample size 
(n=18) of patients with SSi was too small to yield re-
sults that would be statistically significant on multi-
variate analysis of risk factors. 
This study showed that the length of hospital stay 
was significantly higher in patients with SSi, which 
is consistent with other authors’ findings12,15,31. lon-
ger hospital stay may have great impact on health care 
costs, quality of life and final treatment outcome.  
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Sažetak
ČiMBeniCi RiZikA ZA infekCiJu kiRuRŠkOg MJeStA u OPeRACiJAMA kARCinOMA 
gRklJAnA
         J. Sotirović, V. Šuljagić, N. Baletić, Lj. Pavićević, D. Bijelić, M. Erdoglija, A. Perić i I. Soldatović
infekcije kirurškog mjesta (ikM) predstavljaju značajan čimbenik za obolijevanje i smrtnost u bolesnika operiranih 
zbog karcinoma grkljana. Cilj ove prospektivne studije koja je obuhvatila 227 bolesnika bio je odrediti incidenciju ikM 
te utvrditi čimbenike rizika za njezin nastanak. Studija je isključila bolesnike s prethodnom radio- i/ili kemoterapijom. 
Svi su bolesnici imali poslijeoperacijsku traheostomu, a primali su antibiotičku profilaksu koja je sadržavala cefalospo-
rin, aminoglikozid i metronidazol. uočeno je da je srednja incidencija ikM 6,5% (18 bolesnika), uz 4 (22,22%) slučaja s 
površinskom incizijskom infekcijom, 11 (66,22%) s dubokom incizijskom infekcijom i 3 (16,66%) s infekcijom organa ili 
prostora. Ostale infekcije su bile upala pluća (1 bolesnik) i kolitis prouzročen bakterijom Clostridium difficile (2 bolesnika). 
Srednje trajanje bolničkog liječenja u bolesnika kod kojih se razvila ikM bilo je dulje od onih bez ikM (33,5 dana prema 
16 dana;  p<0,001). koristeći univarijatnu analizu nađeno je da su ASA skor ≥3 Američke udruge anesteziologa, kirur-
ška intervencija dulja od 120 minuta i nniS (nacionalno praćenje nozokomijalnih infekcija) indeks rizika ≥1 značajno 
udruženi s pojavom ikM. godine, spol, tjelesna masa, pušenje, dijabetes, duljina prijeoperacijskog boravka u bolnici nisu 
povezani s ikM. najčešće izolirani mikroorganizam je bila Klebsiella spp.   
ključne riječi: Kirurška rana, infekcija; Glava i vrat, tumori – kirurgija; Glava i vrat, tumori – komplikacije; Laringealni 
tumori – epidemiologija; Rizični čimbenici 
